Zifo

Specialist scientific informatics services provider

New York, United States

About Zifo

Zifo provides specialized scientific informatics services to organizations focused on innovation in the fields of Laboratory/R&D, Manufacturing, and Trial operations. Their services include Digital Transformation Coaching, Business Analysis, Program & Project Management, Managed Services, Validation, and Custom Development & Integrations. Zifo leverages expertise in areas such as Chem & Bioinformatics, Data Science, Cloud computing, High-Performance Computing (HPC), Instrument Data, MultiOmics, Data Modeling, Semantics, and Artificial Intelligence & Machine Learning (AI&ML) to deliver tailored solutions. Unlike many competitors, Zifo emphasizes a collaborative approach, ensuring that they understand and address the specific needs of their clients in the scientific community. The company's goal is to support its customers in advancing science and technology, ultimately enhancing global health and wellbeing.

None, New YorkHeadquarters
2008Year Founded
GROWTH_EQUITY_NON_VCCompany Stage
Data & Analytics, Biotechnology, HealthcareIndustries
1,001-5,000Employees

Risks

Emerging competition may pressure Zifo's market share and pricing strategies.
Rapid AI advancements may outpace Zifo's current capabilities, requiring continuous R&D investment.
Data privacy issues could arise from handling sensitive client data amid evolving regulations.

Differentiation

Zifo offers specialized scientific informatics services for enterprise laboratories and R&D operations.
The company provides tailored solutions in Chem & Bioinformatics, Data Science, and AI&ML.
Zifo's strategic alliances enhance its capabilities in laboratory digitization and digital transformation.

Upsides

Zifo's Chennai expansion indicates strong growth and increased market share potential.
Recognition in Deloitte Technology Fast 50 India 2023 highlights Zifo's rapid growth and competitiveness.
TA Associates' investment underscores confidence in Zifo's expansion and innovation potential.

Funding

Total raised$250
StageGROWTH_EQUITY_NON_VC
GROWTH EQUITY NON VC
4/30/2022
$250